BSE
531599

FDC Limited

Drug Manufacturers - Major
Healthcare

Prices are adjusted according to historical splits.

FDC Limited Stock Price

Vitals

Today's Low:
₹372
Today's High:
₹395.2
Open Price:
₹392.55
52W Low:
₹245
52W High:
₹428
Prev. Close:
₹392.55
Volume:
41227

Company Statistics

Market Cap.:
₹59.36 billion
Book Value:
101.006
Revenue TTM:
₹13.34 billion
Operating Margin TTM:
24.29%
Gross Profit TTM:
₹8.97 billion
Profit Margin:
23.19%
Return on Assets TTM:
10.93%
Return on Equity TTM:
19.58%

Company Profile

FDC Limited had its IPO on under the ticker symbol 531599.

The company operates in the Healthcare sector and Drug Manufacturers - Major industry. FDC Limited has a staff strength of 0 employees.

Stock update

Shares of FDC Limited opened at ₹392.55 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹372 - ₹395.2, and closed at ₹375.3.

This is a -4.39% slip from the previous day's closing price.

A total volume of 41,227 shares were traded at the close of the day’s session.

In the last one week, shares of FDC Limited have slipped by -0.9%.

FDC Limited's Key Ratios

FDC Limited has a market cap of ₹59.36 billion, indicating a price to book ratio of 3.2706 and a price to sales ratio of 4.3249.

In the last 12-months FDC Limited’s revenue was ₹13.34 billion with a gross profit of ₹8.97 billion and an EBITDA of ₹3.55 billion. The EBITDA ratio measures FDC Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, FDC Limited’s operating margin was 24.29% while its return on assets stood at 10.93% with a return of equity of 19.58%.

In Q3, FDC Limited’s quarterly earnings growth was a positive 64% while revenue growth was a positive 7.3%.

FDC Limited’s PE and PEG Ratio

Forward PE
0
Trailing PE
18.5429
PEG

Its diluted EPS in the last 12-months stands at ₹18.039 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into FDC Limited’s profitability.

FDC Limited stock is trading at a EV to sales ratio of 3.7835 and a EV to EBITDA ratio of 11.4738. Its price to sales ratio in the trailing 12-months stood at 4.3249.

FDC Limited stock pays annual dividends of ₹1.6 per share, indicating a yield of 0.48% and a payout ratio of 4.42%.

Balance sheet and cash flow metrics

Total Assets
₹23.43 billion
Total Liabilities
₹3.12 billion
Operating Cash Flow
₹111.35 million
Capital Expenditure
₹1.13 billion
Dividend Payout Ratio
4.42%

FDC Limited ended 2024 with ₹23.43 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹23.43 billion while shareholder equity stood at ₹19.82 billion.

FDC Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹3.12 billion in other current liabilities, 165910000.00 in common stock, ₹19.65 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹4.84 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹5.63 million.

FDC Limited’s total current assets stands at ₹10.27 billion while long-term investments were ₹0 and short-term investments were ₹4.59 billion. Its net receivables were ₹1.23 billion compared to accounts payable of ₹0 and inventory worth ₹3.29 billion.

In 2024, FDC Limited's operating cash flow was ₹111.35 million while its capital expenditure stood at ₹1.13 billion.

Comparatively, FDC Limited paid ₹0.04 in dividends in 2024.

Other key metrics

Current Trading Price
₹375.3
52-Week High
₹428
52-Week Low
₹245
Analyst Target Price

FDC Limited stock is currently trading at ₹375.3 per share. It touched a 52-week high of ₹428 and a 52-week low of ₹428. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹364.54 and 200-day moving average was ₹299.99 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6791.6% of the company’s stock are held by insiders while 642.2% are held by institutions.

Frequently Asked Questions About FDC Limited

The stock symbol (also called stock or share ticker) of FDC Limited is 531599

The IPO of FDC Limited took place on

Similar Industry Stocks (Drug Manufacturers - Major)

Last Price
Chg
Chg%
₹642.75
-16.15
-2.45%
₹126.53
-0.48
-0.38%
Corteva Inc (CTVA)
₹51.63
1.82
+3.65%
₹66.3
-4.9
-6.88%
Evgo Inc (EVGO)
₹3.96
0.21
+5.6%
₹0.86
0
+0.47%
₹11.65
-0.45
-3.72%
₹5.73
0.08
+1.46%
₹0.02
-0
-1.8%
₹10.44
-0.05
-0.48%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.

Address

142-48, Swami Vivekananda Road, Mumbai, India, 400102